Who are Solius's investors?

Solius's investors include Lauder Partners.

How much funding has Solius raised?

Solius has disclosed $53.9M raised across 5 rounds.

Where is Solius headquartered?

Solius is headquartered in Bainbridge Island, US.

Solius

Bainbridge Island, US · Delaware corporation · 1 known investors

Find your way into Solius

215 people in our graph share verified history with the Solius team — schools, employers, funds. One of them is your warm intro.

Benji Rosenblattunlockedknows Rick Hennessey · together at Houseamp (overlapped)

knows the team · via Husch Blackwell LLP

×3knows the team · via Lungpacer Medical

×7knows the team · via Sidley Austin LLP

Solius makes an FDA-cleared, over-the-counter UVB light therapy device that analyzes a user's skin tone to deliver a personalized dose of UVB light for vitamin D production and other systemic health benefits. The device pairs with a mobile app for skin analysis and dosing, positioning itself as a controlled alternative to natural sunlight, tanning beds, and traditional phototherapy.

Healthtech Medical Devices Wellness & Fitness

Founders & leadership

Chris Kiple Chief Executive OfficerChris Kiple is Chief Executive Officer of Solius Labs, which develops medical light therapy devices, and Chair of the Board at Lungpacer Medical. He previously served as CEO of Ventec Life Systems for nearly six years, where he led the company through significant growth and oversaw development of the VOCSN Multi-Function Ventilator; earlier in his career, he worked in finance at J.P. Morgan, law at Sidley Austin, and government affairs at Husch Blackwell. He holds a degree in International Affairs and a law degree from George Washington University.

Robert WiseExecutive

Alexander MoffatExecutive

Rick Hennessey Investor2013–2019Rick Hennessey has built and sold five technology companies and held leadership roles at public firms traded on the NYSE and NASDAQ. He is a co-founder of Cequint, a mobile technology firm that commercialized CallerID technology and was sold for over $100 million; through a family office, he invests in medtech, fintech, and real estate ventures.

Dave GoodChief Special Projects Officer

Board

Christopher AckerleyBoard director

Brett Parent Investor and Board MemberFounder; Manager at WellWay Diagnostics

Scott HirschBoard director

Rick WhiteBoard director

Elwood HowseBoard director

Investors · 1

Lauder Partnerslisted by Lauder PartnersLos Altosvia Gary Lauder · inferred

How we know: Lauder Partners's portfolio page · offering press articles · Not right? Tell us

Funding

SEC filings, press & company announcements

$53.9M disclosed across 5 rounds · 2014–2026

$23MraisedJun 2026
Source ↗

▶$3.5MraisedMay 2026 · 2 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Chris KipleExecutive Officer, Director
Robert WiseExecutive Officer
Brett ParentDirector
Scott HirschDirector
David GoodExecutive Officer
Christopher AckerleyDirector
Rick WhiteDirector

Offering amount: $17.9M
Amount sold: $3.5M
First sale: Apr 2026
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$23.5MraisedMay 2026 · 11 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Rick WhiteDirector
Brett ParentDirector
Scott HirschDirector
Robert WiseExecutive Officer
David GoodExecutive Officer
Chris KipleExecutive Officer, Director
Christopher AckerleyDirector

Offering amount: $23.5M
Amount sold: $23.5M
First sale: Mar 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$788.2KraisedOct 2018 · 4 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Brett R ParentDirector
Elwood Denison HowseDirector
Rick J. HenneseyExecutive Officer, Director
William Alexander MoffatDirector
Bob WiseExecutive Officer
Christopher H AckerleyDirector

Offering amount: $12.8M
Amount sold: $788.2K
Sales commissions: $5K
Placement agents: Capital Suisse LLC
First sale: Oct 2018
Incorporated: Corporation, Washington
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3.1MraisedDec 2015 · 23 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Alexander MoffatExecutive Officer, Director, Promoter
Elwood HowseDirector
Rick HennesseyExecutive Officer, Director, Promoter

Offering amount: $7M
Amount sold: $3.1M
Minimum investment: $10K
First sale: Nov 2014
Incorporated: Corporation, Washington, 2011
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

4 people who came through Solius went on to found or lead other companies.

Chris KipleExecutive Officer, DirectorFounded Ventec Life Systems Rick HennesseyExecutive Officer, Director, PromoterFounded Houseamp Brett ParentDirectorFounded WellWay Diagnostics Sen WenCTOFounded Cardfree

Competitors · 3

by search overlap

Cancerresearchuk27 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.

Ro25 shared keywordsRo is an online healthcare platform that connects patients with licensed providers and delivers prescription treatments, including GLP-1 medications for weight loss, ED treatments, and other health goals. The direct-to-consumer telehealth service is fully online and serves individual patients in the United States.

Uclahealth22 shared keywordsUCLA Health is a major academic health system providing patient care across five hospitals and 290 clinics in Southern California and the Central Coast, alongside research and medical education. The organization conducts pioneering research in oncology, transplantation, neurosurgery, and other specialties, having contributed to the development of numerous FDA-approved treatments.

Companies competing with Solius for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Solius do?: Solius makes an FDA-cleared, over-the-counter UVB light therapy device that analyzes a user's skin tone to deliver a personalized dose of UVB light for vitamin D production and other systemic health benefits. The device pairs with a mobile app for skin analysis and dosing, positioning itself as a controlled alternative to natural sunlight, tanning beds, and traditional phototherapy.
Who are Solius's investors?: Solius's investors include Lauder Partners.
How much funding has Solius raised?: Solius has disclosed $53.9M raised across 5 rounds.
Where is Solius headquartered?: Solius is headquartered in Bainbridge Island, US.